NO20053689L - Fremgangsmate for fremstilling av quinazolin alkaloider. - Google Patents

Fremgangsmate for fremstilling av quinazolin alkaloider.

Info

Publication number
NO20053689L
NO20053689L NO20053689A NO20053689A NO20053689L NO 20053689 L NO20053689 L NO 20053689L NO 20053689 A NO20053689 A NO 20053689A NO 20053689 A NO20053689 A NO 20053689A NO 20053689 L NO20053689 L NO 20053689L
Authority
NO
Norway
Prior art keywords
compound
preparation
iii
preparing
formula
Prior art date
Application number
NO20053689A
Other languages
English (en)
Inventor
Hans-Rainer Hoffmann
Rudolf Matusch
Joachim Moormann
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32747532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053689(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20053689L publication Critical patent/NO20053689L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Oppfinnelsen angår fremgangsmåter for fremstilling av en forbindelse med følgende formel (I) (II) ved omdanning av en forbindelse med formel (II) med 2-pyrrolidon, nevnte 2-pyrrolidon blir benyttet i overskudd, relativ til forbindelse (II); sa vel som fremgangsmater for fremstilling av en forbindelse med f0lgende formel (III) omfatter de følgende trinnene: (A) fremstilling av forbindelse (I); (B) reduksjonsreaksjon, hvilket gir forbindelse (III) i salt form; (C) frigjøring av forbindelse (III) fra saltet.
NO20053689A 2003-02-03 2005-07-29 Fremgangsmate for fremstilling av quinazolin alkaloider. NO20053689L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10304141A DE10304141B4 (de) 2003-02-03 2003-02-03 Verfahren zur Herstellung von Chinazolin-Alkaloiden
PCT/EP2004/000485 WO2004069836A1 (de) 2003-02-03 2004-01-22 Verfahren zur herstellung von chinazolin-alkaloiden

Publications (1)

Publication Number Publication Date
NO20053689L true NO20053689L (no) 2005-07-29

Family

ID=32747532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053689A NO20053689L (no) 2003-02-03 2005-07-29 Fremgangsmate for fremstilling av quinazolin alkaloider.

Country Status (26)

Country Link
US (1) US7495096B2 (no)
EP (1) EP1590351B1 (no)
JP (1) JP2006516578A (no)
KR (1) KR20050096165A (no)
CN (1) CN100558727C (no)
AR (1) AR042946A1 (no)
AT (1) ATE407135T1 (no)
AU (1) AU2004208873B2 (no)
BR (1) BRPI0407012A (no)
CA (1) CA2514945A1 (no)
DE (2) DE10304141B4 (no)
DK (1) DK1590351T3 (no)
EA (1) EA009047B1 (no)
ES (1) ES2314366T3 (no)
HK (1) HK1075898A1 (no)
MX (1) MXPA05008179A (no)
MY (1) MY141734A (no)
NO (1) NO20053689L (no)
NZ (1) NZ541101A (no)
PL (1) PL378406A1 (no)
PT (1) PT1590351E (no)
SI (1) SI1590351T1 (no)
TW (1) TW200418811A (no)
UA (1) UA81287C2 (no)
WO (1) WO2004069836A1 (no)
ZA (1) ZA200505160B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004048927A1 (de) * 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
AU2018309085B2 (en) * 2017-08-03 2022-12-08 Galectin Sciences, Llc Compounds for the prevention and treatment of medical disorders and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
JP3180464B2 (ja) * 1991-08-30 2001-06-25 新日本理化株式会社 ジアセタール化合物の製造方法
DE19530606A1 (de) * 1995-08-21 1997-02-27 Basf Ag 1-(Pyridyl)-pyrazole
JP3958452B2 (ja) * 1997-10-31 2007-08-15 大日精化工業株式会社 新規化学発光試薬及びその製造方法
DE19906975B4 (de) 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Also Published As

Publication number Publication date
EP1590351B1 (de) 2008-09-03
PT1590351E (pt) 2008-11-21
EA200501135A1 (ru) 2006-02-24
US20060084669A1 (en) 2006-04-20
BRPI0407012A (pt) 2006-01-10
WO2004069836A1 (de) 2004-08-19
NZ541101A (en) 2009-03-31
SI1590351T1 (sl) 2009-02-28
CA2514945A1 (en) 2004-08-19
CN100558727C (zh) 2009-11-11
CN1745084A (zh) 2006-03-08
US7495096B2 (en) 2009-02-24
KR20050096165A (ko) 2005-10-05
DE10304141B4 (de) 2006-03-09
AU2004208873A1 (en) 2004-08-19
TW200418811A (en) 2004-10-01
ES2314366T3 (es) 2009-03-16
DE502004007980D1 (de) 2008-10-16
JP2006516578A (ja) 2006-07-06
PL378406A1 (pl) 2006-04-03
ZA200505160B (en) 2007-01-31
EP1590351A1 (de) 2005-11-02
DK1590351T3 (da) 2008-12-15
EA009047B1 (ru) 2007-10-26
AU2004208873B2 (en) 2009-12-17
MXPA05008179A (es) 2006-02-17
AR042946A1 (es) 2005-07-06
HK1075898A1 (en) 2005-12-30
UA81287C2 (en) 2007-12-25
DE10304141A1 (de) 2004-08-26
ATE407135T1 (de) 2008-09-15
MY141734A (en) 2010-06-15

Similar Documents

Publication Publication Date Title
MX2009003698A (es) Preparacion de azoxistrobina.
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
TW200736258A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MY144657A (en) Crystalline polymorphs of a cxc-chemokine receptor ligand.
DE502006008395D1 (de) Verfahren zur herstellung von metallorganischen gerüstmaterialien hauptgruppen metallionen enthaltend
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2003097614A3 (en) Process for the preparation of rosuvastatin
WO2005085236A3 (en) Caspase inhibitors and uses thereof
UA99447C2 (ru) Способ получения силденафила
WO2007109810A3 (en) Methods for the preparation of imidazole-containing compounds
WO2008035212A3 (en) Processes for preparing intermediate compounds useful for the preparation of cinacalcet
WO2006066044A3 (en) Processes for producing 4-aminoquinazolines
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
ATE419240T1 (de) Verfahren zum herstellen von 5-fluor-1,3-dialkyl- 1h-pyrazol-4-carbonsäurefluoriden
NO20071817L (no) Fremgangsmate for a fremstille enantiomeriske imidazolforbindelser
WO2007029084A3 (en) A process for the preparation of carbapenem compounds
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
NO20053689L (no) Fremgangsmate for fremstilling av quinazolin alkaloider.
WO2004002990A3 (en) Synthesis of purine derivatives
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
TW200624435A (en) Process for preparing iridium(Ⅲ) ketoketonates
WO2006043175A3 (en) Process for preparing purine compounds
EA200701163A1 (ru) Способ получения анилинов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
RE Reestablishment of rights (par. 72 patents act)